A sign is seen outside the JPMorgan office in Los Angeles
A sign is seen outside the JPMorgan office in Los Angeles, Calif., Oct. 12, 2010. Reuters

LiveDeal, Orexigen Therapeutics, Lincare Holdings, Synta Pharmaceuticals, Barclays, JPMorgan Chase and Deutsche Bank are among the companies whose shares are moving in pre-market trading Thursday.

LiveDeal Inc. (LIVE) stock climbed 9.99 percent to $12.11 in pre-market trading. The company stock climbed nearly 18 percent in regular trading Wednesday.

Orexigen Therapeutics, Inc. (OREX) stock surged 4.47 percent to $5.14 in pre-market trading. The stock has a 52-week low of $1.22, a 52-week high of $5.57 and $333.47 million in market capitalization.

Lincare Holdings Inc. (LNCR) stock gained 2.60 percent to $31.98 in pre-market trading. The company stock climbed more than 23 percent Wednesday on news that Linde AG may acquire LNCR for at least $3.4 billion.

Synta Pharmaceuticals, Inc. (SNTA) stock slumped 20 percent to $5.80 in pre-market trading after announcing results from a planned interim analysis of the company’s experimental treatment for nonsmall cell lung cancer.

Barclays Plc (BCS) stock slumped 8.60 percent to $11.27 in pre-market trading. On Wednesday, the bank agreed to pay $453 million to the U.S. and British authorities for its alleged involvement in a scheme to manipulate two global benchmark interest rates.

JPMorgan Chase & Co. (JPM) stock plunged 4.92 percent to $34.97 in pre-market trading after news that company’s loss from the 'London Whale' event that saw employee Bruno Iksil lose billions in a bad hedging bet, could total as much as $9 billion, far higher than earlier public estimates of $2 billion, the New YorkTimes reported citing unidentified current and former traders and executives at the bank.

Deutsche Bank AG (DB) stock plunged 4.36 percent to $33.78 in pre-market trading. The stock has a 52-week low of $28.57, a 52-week high of $61.23 and $32.58 million in market capitalization.

Barclays Deutsche Bank Jpmorgan chase Cancer